Clorox director Breber buys 4,000 shares via trust

A director's purchase was reported as an indirect trust transaction, with 22,000 shares held afterward.

Available on EDGAR 11/05/2026 - 04:16 PM EST Accepted by SEC EDGAR 11/05/2026 - 04:16 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Clorox (CLX) director Pierre R. Breber reported an indirect purchase of 4,000 shares through a trust on November 4, 2026. The reported price was $100.0627 per share, and reported holdings following the purchase were 22,000 shares. A footnote says the trades ranged from $99.4400 to $101.0000 and describes the reported figure as a weighted-average sale price. No Rule 10b5-1 plan is reported.

Insider Trade Summary

Net Buyer: 4,000 shares

Net Buy 1 txn

Insider Breber Pierre R

Role Director

Bought 4,000 shs ($400K)

Increase in Position 22.2%

Type	Security	Shares	Price	Value
Purchase	Common Stock F1	4,000	$100.0627	$400K

Holdings After Transaction: Common Stock — 22,000 shares (Indirect, By Trust)

Holdings Before and After: Common Stock, 18,000 to 22,000 shares (Indirect, By Trust)

Footnotes (1)

1. F1. This transaction was executed in multiple trades at prices ranging from $99.4400 to $101.0000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Key Figures

Shares purchased: 4,000 shares Reported price per share: $100.0627 per share Trade range low: $99.4400 per share +2 more

5 metrics

Shares purchased 4,000 shares Reported November 4, 2026; through a trust

Reported price per share $100.0627 per share Purchase reported November 4, 2026

Trade range low $99.4400 per share Range stated in the transaction footnote

Trade range high $101.0000 per share Range stated in the transaction footnote

Shares following transaction 22,000 shares Reported holdings after the purchase

Key Terms

weighted average sale price, non-derivative, indirect ownership

3 terms

weighted average sale price financial

"the reported figure reflects the weighted average sale price"

non-derivative financial

"the Common Stock purchase was reported as a non-derivative transaction"

indirect ownership financial

"the purchase was reported as indirect ownership through a trust"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CLX shares did director Pierre R. Breber purchase, and at what price?

Pierre R. Breber reported an indirect purchase through a trust of 4,000 shares on November 4, 2026, at a reported $100.0627 per share. A footnote gives a trade range of $99.4400 to $101.0000 and describes the reported figure as a weighted-average sale price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Breber Pierre R

(Last) (First) (Middle)

1221 BROADWAY

(Street)

OAKLAND CALIFORNIA 94612-1888

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CLOROX CO /DE/ [ CLX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/04/2026		P		4,000	A	$100.0627(1)	22,000	I	By Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This transaction was executed in multiple trades at prices ranging from $99.4400 to $101.0000. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

	By Jinho Joo, Attorney-in-Fact	11/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)